Search Results

Displaying: 25 / 100 / 200 results

Ordered by: Date (newest first) / Date (oldest first)

US pushes for global phase-out of HFCs

19 September 2014 Business

Executive actions and industry commitments aim to speed up adoption of alternatives to hydrofluorocarbon greenhouse gases in refrigeration and air conditioning

Freeing a world of fixers

16 September 2014 Business

Company profile: Sugru mouldable silicone rubber lets you mend what’s broken and hack stuff better

Eastman snaps up Taminco for $2.8bn

12 September 2014 Business

Purchase will strengthen Eastman in niche markets and offers cost savings

Pharma sales ‘will reach $1 trillion’ in 2014

11 September 2014 Business

Report predicts continued growth as sales reach an all-time high

Growth slow for European chemicals in 2014

10 September 2014 Business

Results for the first half held back by stagnant sales and production dips

Cipla targets asthma market with Advair copy

10 September 2014 Business

Indian pharma company Cipla has launched a generic version of GSK’s best selling drug

BP faces $18bn fine over Deepwater

9 September 2014 Business

US judge rules that BP’s recklessness caused blowout through ‘gross negligence or willful misconduct', but the firm will appeal

Servier to appear in adverts over lack of transparency

5 September 2014 Business

Adverts in the medical press will name French pharma firm for failing to comply with disclosure rules

Halliburton settles Deepwater Horizon claims

3 September 2014 Business

Company will pay $1.1bn for damage to property and commercial fishing

Novo Nordisk quits inflammation R&D and cuts jobs

3 September 2014 Business

Firm will return to primary focus on diabetes and obesity

Piramal exits drug discovery in India

3 September 2014 Business

Company will concentrate on generic medicines and clinical and contract research.

Exelexis slashes workforce by 70%

2 September 2014 Business

Poor clinical trial performance pushes company into cost-cutting drive

Roche to buy InterMune for respiratory boost

29 August 2014 Business

$8.3bn deal gives Roche a leading position in pulmonary fibrosis

DuPont settles pollution charges for $1.3m

28 August 2014 Business

Allegations relate to eight hazardous chemical leaks in West Virginia between 2006 and 2010

Clinical collaborations drive cancer immunotherapy

27 August 2014 Business

Companies race to pair up chemotherapy drugs with immune system-boosting antibodies to greatest effect in trials

Illumina targets cancer diagnostics

22 August 2014 Business

Sequencing will improve tests and speed up clinical trials processes for big pharma partners

Sanofi snaps up inhaled insulin licence

12 August 2014 Business

Deal gives Mannkind access to global manufacturing and distribution for recently-approved Afrezza

Single shot antibiotic approved for skin infections

11 August 2014 Business

Third drug in three months approved under US antimicrobials incentive scheme

GSK’s China troubles continue

6 August 2014 Business

Analysts say stings will only drive corruption into less visible channels

Tetraethyl lead bribery case ends with four executives convicted

5 August 2014 Business

Three jailed over corruption to prolong sales of fuel additives in Iraq and Indonesia

Price caps provoke lawsuits from Indian pharma industry

5 August 2014 Business

New government controls on cardiovascular and diabetes drugs challenged by industry lobby groups

Amgen to shed 2400-2900 jobs

1 August 2014 Business

Restructuring will see three sites close as company comes under pressure to streamline R&D, despite successes

AstraZeneca stocks respiratory and cancer pipelines

31 July 2014 Business

A $2bn deal with Almirall and a raft of acquisitions and partnership deals bulk up two focus areas for the company

Bruker winds down underperforming instrument lines

30 July 2014 Business

Stand-alone gas chromatographs and certain mass spectrometry products to be sold off

Reckitt Benckiser to spin out US pharma arm

28 July 2014 Business

Declining heroin addiction treatment sales prompt divestment as company focuses on over-the-counter and consumer products